Clinical Trial Update: Nitroglycerin Ointment for Preventing Bone Loss in Postmenopausal Women [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating nitroglycerin ointment to prevent bone loss in postmenopausal women with osteoporosis or osteopenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia
• Osteoporosis

Drugs mentioned

• Nitroglycerin ointment (nitroglycerin)

Snippet

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Conditions: Osteoporosis, Osteopenia | Phase 3 | Status: COMPLETED